SUBJECTS AND METHODS
Of the 139 patients who underwent excision for invasive cancer in the pancreatic duct in our Hospital between January 1965 and December 1998, the sub jects were 38 patients in whom blood vessels around the cancer were simultaneously excised. The surgical methods were PD in 31 patients, DP in 5, and TP in 2. In the 38 patients, the reconstruction method of blood vessels, postoperative complications, long-term survival and cumulative survival rate were examined. Histological findings were recorded according to the rules of treatment of pancreatic cancer [1] . The cumu lative survival rate was determined by the KaplanMeier method. Differences were examined by the generalized Wilcoxon test, and a value of p<0.05 was regarded as significant.
RESULTS
The excised blood vessels were the portal vein in the patient who had undergone excision of the artery alone, while 4 of the 5 patients (80%) who had undergone simultaneous excision of the portal vein and artery had postoperative complications, which were hepatic dysfunction in 2 and hepatic abscess in 2. The 2 patients with hepatic abscess who also had sepsis and pneumonia died 54 days and 101 days, respectively, after surgery (Table 5 ). Three patients with pvo, pvl or pv2 survived for more than 3 years. The longest survival period was 17 years 5 months among the patients who had undergone simultaneous excision of the portal vein alone, while it was 1 year 6 months in the patient with pvo/al of those who had undergone simultaneous excision of the portal vein and artery. Among the patients without simultaneous excision of the portal vein, the 1-year survival rate was 49.3%, the 3-year survival rate was 17.9%, and the 5-year survival rate was 9.3%, while among the patients with simultaneous excision of the portal vein, 1-year, 3-year and 5-year survival rates were 45.9%, 9.7% and 6.5%, respectively, indicating that the cumulative survival rates were slightly higher in the former than in the latter. However, there were no differences between the 2 groups (Fig. 1) .
DISCUSSION
In pancreatic cancer, infiltration into the portal vein occurs in the early stage because of the anatom ical specificity of the pancreas. Removal of the pan creatic cancer is often impossible without simulta neous excision of cancer tissues and the surrounding blood vessels. Since Fortner reported on regional pancreatectomy in 1973 [2] , simultaneous excision of cancer tissues and the surrounding blood vessels has been widely performed including Japan. In some institutions, excision of the portal vein is performed only when infiltration into the portal vein is con firmed by imaging, while in other institutions, excision of the portal vein is performed irrespective of its conditions because the portal vein is considered to be part of the pancreas [3] [4] [5] [6] [7] . The rate of simulta neous excision of the portal vein in pancreatic cancer was reported to be 64.0% by Nakao et al. [7] , 53.6% by Ogata et al. [3] , and 30.4% by Sano et al. [5] . In our department, it was 26.6% (37 of 137 patients), which was lower than in other institutions. In our hospital, simultaneous excision of the portal vein is applied to patients who have been diagnosed as having infiltration into the portal vein by preoper ative portography and observation during surgery, and this is probably the reason for the low incidence. If the excised veins are shorter than 5 cm, recon struction is possible by end-to-end anastomosis, while if they are longer than 5 cm, transplantation of the autologous vein between the ends is considered necessary. In our department, 2 patients underwent reconstruction by the latter method. The length of the excised vein was 7 cm in one patient, while it was shorter than 5 cm in the other but transplantation of the autologous vein between the ends was performed because the anastomotic region was considered to be under stress. Autologous veins are used for trans plantation between the ends of the portal veins for reconstruction in many institutions, but there have been also studies on transplantation using artificial blood vessels [8-10]. In our department, artificial blood vessels have not been used for reconstruction, and we consider that use of artificial blood vessels should be avoided in surgery of the digestive tract where contamination is likely to occur.
The problems of reconstruction of excised portal veins are hemostasis of the mesenteric vein and ischemia in the liver during blocking of the portal vein. To prevent hemostasis of the mesenteric vein and elevation of portal pressure, blocking of the SMA and a bypass from the mesenteric vein to the femoral vein using an anthrone tube are performed. Imaizumi et al. [6] reported that there were no clinical prob lems of hemostasis of the mesenteric vein and ischemia in the liver because blocking of the portal vein was required only for about 30 min for recon struction, and indicated thaat there was no necessity of blocking of the SMA and construction of a bypass. We usually block the SMA to prevent hemostasis of the mesenteric veins and edema of the intestinal wall, but have not encountered complications caused by the blocking of the SMA. Nakao et al. [11] reported that the use of a bypass enables surgeons to perform anastomosis without haste and can prevent hemosta sis of the intestine and elevation of portal pressure. Because the blocking of the portal vein is prolonged with prolongation of anastomosis using substitute blood vessels, the bypass method is used in our department. We have performed anastomosis in 3 patients by this method with a bypass from the mesen teric vein to the femoral vein using an anthrone tube.
The complications caused by reconstruction of the portal vein are hemorrhage from the anastomotic region, intestinal infarction by thrombolic obstruc tion or hemostatic symptoms, diarrhea and dejection disorder, but none of the patients had such complica tions. Harrison et al. [12] examined the death rate during the period of hospitalization and the mean survival period in 58 patients who had undergone simultaneous excision of the portal vein in 332 patients with pancreatic cancer in whom the pancreas had been excised, and reported that there were no differences between the patients with and without simultaneous excision of the portal vein, indicating that excision of the portal vein in pancreatic cancer should not be restricted. Complications after simulta neous excision of the portal vein alone are not severe, and the surgical techniques are relatively safe. However, because of the high incidence of complications and death after simultaneous excision of the portal vein and artery, application of this method should be carefully performed from the viewpoint of quality of life. Takahashi et al. [13] reported on early recurrence in patients who had undergone histologically complete excision of cancer tissues and simultaneous excision of arteries, and indicated that improvement of the quality of limited prognosis is more important than improvement of the rate of radical treatment in highly advanced pancre atic cancer. Among the patients who had undergone simultaneous excision of the portal vein, 1 patient with pvl and 1 with pv2 in whom cancer tissues were histologically observed on the wall of the portal vein survived for more than 3 years, indicating that simul taneous excision of the portal vein was effective. 
